By constructing tamoxifen-perturbed signaling pathways using phosphoproteomic analysis, Browne, et al. 39 discovered a substrate protein, the myristoylated alanine-rich C-kinase substrate (MARCKS) protein, as a potential biomarker for anti-estrogen tamoxifen-resistant breast cancer. Here, MARCKS is linked to breast carcinoma.